Organogenesis Holdings Inc. — Director's Dealing 2016

Oct 8, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Avista Healthcare Public Acquisition Corp. (AHPA)
CIK: 0001661181
Period of Report: 2016-10-07

Reporting Person: O'Neil Robert P (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Class B Ordinary Shares	$		Class A Ordinary Shares (471250)		Direct

Footnotes

F1: The reporting person holds an aggregate of 471,250 Class B ordinary shares, par value $0.0001 per share (the "Class B Shares"), including 56,250 shares that are subject to forfeiture if the underwriters of the Issuer's initial public offering do not exercise in full an option granted to them to cover over-allotment. Pursuant to the Amended and Restated Memorandum and Articles of Association (the "Articles") of the Issuer, such Class B Shares will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the Issuer at the time of the Issuer's Business Combination, as defined in the Articles, on a one-for-one basis, subject to adjustment, and have no expiration date.